Hyundai Pharm Co. Ltd.
http://www.hyundaipharm.co.kr
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Hyundai Pharm Co. Ltd.
Asia Deal Watch: Bharat Expands Its Vaccine Holdings By Buying GSK’s Chiron Behring
Bharat hopes to expand international reach of Chiron Behring’s rabies vaccine. WuXi and Biolingus partner on sublingual delivery.
Deal Watch: Merck KGAA, Pfizer, eFFECTOR Agree To PD-L1/MNK Combo Study In CRC
Recently approved Bavencio will be paired with experimental MNK1/2 inhibitor in microsatellite-stable colorectal cancer. CRO Parexel to go private, AbbVie teams with Principia in immunology R&D and more.
PharmAsia News Business Bulletin
A new regular roundup of commercial stories appearing in Scrip's sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace.
First Asian launch for ulipristal, in South Korea
HRA Pharma has launched the emergency oral contraceptive ellaOne (ulipristal acetate) in South Korea through its licensee for this market, Hyundai Pharm.
Company Information
- Industry
-
Pharmaceuticals
- OTC, Consumer
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice